Neonatal hypothyroidism is a condition characterized by inadequate thyroid function in newborns. This disease can lead to various consequences, including delayed physical and mental development, if not diagnosed and treated promptly. Hypothyroidism can be caused by both congenital anomalies (such as agenesis or dysplasia of the thyroid gland) and acquired factors. This article will review neonatal hypothyroidism from various aspects, from historical facts to modern approaches to diagnosis and treatment.
History of the disease and interesting historical facts
The history of hypothyroidism research dates back to ancient times, when various civilizations observed signs of mental and physical retardation that could be associated with thyroid dysfunction. The first documented case of hypothyroidism was in the 18th century, when the French physician Marie-Joseph Gauly thoroughly studied the symptoms similar to those observed in today's understanding of this condition. Later, in the early 20th century, links were established between thyroid hormone levels and human physical development. In the 1970s, a large-scale neonatal screening program for hypothyroidism began, which significantly increased the chances of early diagnosis and effective treatment of this condition.
Epidemiology
Neonatal hypothyroidism is one of the most common endocrine disorders in newborns. According to statistics, its incidence is about 1 case per 3-4 thousand live births, but this value may vary depending on the geographic region and ethnicity. In countries with mass screening, the incidence can be detected much earlier and quantitatively, which allows for the introduction of effective preventive measures. There is evidence that the predisposition to the development of the disease may be higher in low birth weight newborns, as well as in children born to mothers with autoimmune diseases.
Genetic predisposition to this disease
Research shows that hereditary factors play a significant role in the development of neonatal hypothyroidism. Some pathogenic mutations in the genes responsible for the synthesis of thyroid hormones can lead to disruption of their production. The genes involved include:
- thyroglobulin (TG)
- thyroid lymphocyte receptor (TSHR)
- components of thyroid hormone synthesis, such as the NIS gene (sodium-iodine-air symporter).
Molecular analysis shows that some cases of neonatal hypothyroidism are associated with autosomal recessive or autosomal dominant inheritance patterns. This highlights the importance of genetic counseling for families with a history of the disorder.
Risk factors for the development of this disease
There are a number of factors that can increase the risk of developing neonatal hypothyroidism. These include:
- genetic predisposition, especially in cases of thyroid disease in relatives;
- exposure to certain chemicals, such as nitrates and perchlorate, which can affect thyroid function;
- pregnancy with the use of certain medications, such as antidepressants and anticonvulsants;
- existing maternal autoimmune diseases such as Hashimoto's thyroiditis;
- lack or insufficient intake of iodine into the mother's body during pregnancy.
Studying these factors is important for developing preventive measures and screening in newborns.
Diagnosis of this disease
The main symptoms of neonatal hypothyroidism may be nonspecific and include:
- weak sucking reflex;
- atherosclerotic masses and edema;
- decreased muscle tone and delayed development;
- skin manifestations such as dryness and yellowness;
- problems with thermoregulation.
Laboratory tests include measuring TSH (thyroid stimulating hormone) and free T4 (tetrahydrothyronine). Elevated TSH with low T4 indicates hypothyroidism. Radiologic tests are not usually the first step in diagnosis but may be used to evaluate the thyroid function. The differential diagnosis includes ruling out other causes of hypothyroidism, such as transient hypothyroidism caused by physical or chemical stress.
Treatment
Treatment of neonatal hypothyroidism typically involves replacement therapy with synthetic thyroid hormones. Common treatment approaches include:
- mandatory administration of levothyroxine (T4) at an early age;
- regular blood level checks to adjust the dose;
- constant monitoring of the child's development.
Pharmacological treatment is limited to individual selection of levothyroxine dose depending on TSH level and clinical condition of the patient. Surgical treatment is used rarely, as an exceptional measure, in case of detection of neoplasms. Other types of treatment may include administration of appropriate vitamins and supportive therapy to correct concomitant diseases.
List of medications used to treat this disease
The main medications used to treat neonatal hypothyroidism include:
- Levothyroxine (T4)
- Triiodothyronine (T3) – as needed
- Drugs to support cardiovascular function
- Vitamin D for Correction of Metabolic Disorders
- Additional chelates if necessary to correct iodine status.
The correct choice of medications and their dosages play a significant role in achieving normalization of hormonal levels.
Disease monitoring
Monitoring of patients with neonatal hypothyroidism includes regular control tests for TSH and T4 levels. The total number of control stages is determined individually, but usually amounts to:
- every 1-2 months at the initial stage of treatment;
- every 3-6 months as the condition stabilizes;
- annual check-ups after normal hormone levels have been achieved.
The prognosis for most patients with neonatal hypothyroidism is encouraging if replacement therapy is started promptly, but complications, including delayed physical and mental development, are possible if treatment is delayed.
Age-related features of the disease
The manifestations of neonatal hypothyroidism may vary depending on the age of the patient. Newborns often have pronounced symptoms such as low tone and edema, while older children may have less pronounced manifestations. Adults who experienced hypothyroidism in childhood may have changes in metabolism and function of various organs, which requires an individual approach to monitoring and treatment.
Questions and Answers
- What are the main symptoms of neonatal hypothyroidism? Key symptoms include a weak sucking reflex, swelling, delayed growth, and problems with thermoregulation.
- How is this disease diagnosed? Diagnosis is based on TSH and T4 level tests, as well as clinical examinations.
- What is the treatment for neonatal hypothyroidism? Treatment consists of levothyroxine replacement therapy and regular monitoring of hormone levels.
- What is the prognosis for children with neonatal hypothyroidism? With timely treatment, the prognosis is usually favorable, and the child’s development becomes normal.
- What influence do genetic factors have? Genetic factors may increase the risk of developing the disease and require monitoring in families with a history of hypothyroidism.
